SPINAL MUSCULAR ATROPHY TYPE 3
Clinical trials for SPINAL MUSCULAR ATROPHY TYPE 3 explained in plain language.
Never miss a new study
Get alerted when new SPINAL MUSCULAR ATROPHY TYPE 3 trials appear
Sign up with your email to follow new studies for SPINAL MUSCULAR ATROPHY TYPE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for babies with SMA: trial tests Muscle-Strengthening drug
Disease control Recruiting nowThis study is testing an investigational drug called apitegromab in infants under 2 years old who have spinal muscular atrophy (SMA). The main goal is to see how the drug moves through the body, how it affects a specific muscle protein, and if it can improve gross motor skills, l…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Smart insoles could reveal hidden clues in Kids' steps
Knowledge-focused Recruiting nowThis study aims to develop better ways to measure how diseases like Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA) progress over time. Researchers will have 106 children wear special 'smart' insoles in their shoes to track their walking patterns both in a lab…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Can your walk predict a broken bone? new study investigates
Knowledge-focused Recruiting nowThis study aims to understand if specific walking patterns, measured with special shoe insoles, can serve as early warning signs for bone weakness and fracture risk in people with Spinal Muscular Atrophy (SMA) who can walk. It involves 22 participants aged 8-50 and is observation…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Sponsor: Jacqueline Montes • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC